Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Regarding the PTSC Annual SHM held on 1/28/2010

If the company buys back the shares and then those shares pay dividends the dividend money of those shares would be controlled by the BOD. The board could then pay a higher dividend to fewer shareholders or give themselves a bigger salary. I wonder which course they would take.

Share
New Message
Please login to post a reply